Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

169
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 09/30 05:23:50 pm
282.6000 DKK   -0.49%
5d ago NOVO NORDISK A/S : establishes new obesity research unit in Seattle
09/22 NOVO NORDISK A/S : Share repurchase programme
09/22 Novo Nordisk A/S - Share repurchase programme
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on NOVO NORDISK A/S
1d ago NOVO NORDISK A/S : EtQ to Present Global Quality Workflow Webinar with Novo Nord..
1d ago NOVO NORDISK A/S : Merrion Pharmaceuticals Announces Interim Results For The Six..
1d ago NOVO NORDISK A/S : establishes new obesity research unit in Seattle
5d ago NOVO NORDISK A/S : partners with EGYVAC to start human Insulin factory in Egypt
5d ago NOVO NORDISK A/S : Research Data from Novo Nordisk Update Understanding of Gener..
5d ago NOVO NORDISK A/S : establishes new obesity research unit in Seattle
6d ago NOVO NORDISK A/S : Patent Issued for Method for Making Acylated Polypeptides
6d ago NOVO NORDISK A/S : Patent Application Titled "Pharmaceutical Compositions for Or..
6d ago NOVO NORDISK A/S : Congress, MAGIC Call for Early Detection and Awareness of Chi..
6d ago NOVO NORDISK A/S : New Findings from Novo Nordisk in Systemic Lupus Erythematosu..
09/23 NOVO NORDISK A/S : PATH and Novo Nordisk Announce Clinton Global Initiative Comm..
09/23 NOVO NORDISK A/S : Strativity Unveils Next Generation Customer Experience Educat..
09/22 NOVO NORDISK A/S : Share repurchase programme
09/22 Novo Nordisk A/S - Share repurchase programme
09/19 NOVO NORDISK A/S : Reed receives diabetes champion award
09/19 NOVO NORDISK A/S : Supports National Hemophilia Foundation Initiative for "Colla..
09/19 NOVO NORDISK A/S : -Xultophy (IDegLira) approved in Europe
09/19 NOVO NORDISK A/S : New Xultophy® (IDegLira) data show rapid and predictable glyc..
09/18DJLilly's Type 2 Diabetes Drug Trulicity Gets FDA OK -- Update
09/18DJLilly's Type 2 Diabetes Drug Trulicity Gets FDA OK -- 2nd Update
09/18 NOVO NORDISK A/S : Xultophy® (IDegLira) approved in Europe
09/18 NOVO NORDISK A/S : Xultophy(r) (IDegLira) approved in Europe
09/18 NOVO NORDISK A/S : May Hire Hundreds Of R%7ED Employees To Develop Obesity Medic..
09/18 NOVO NORDISK A/S : Marks 90 Years of Innovating Diabetes Care
09/18 NOVO NORDISK A/S : Ryzodeg® provides successful glycaemic control with fewer inj..
09/17 NOVO NORDISK A/S : New Peptides and Proteins Study Results Reported from Novo No..
09/17 NOVO NORDISK A/S : Saxenda® for the treatment of obesity receives positive 14-1 ..
09/16 NOVO NORDISK A/S : New data show long-term efficacy and safety of Tresiba® in ch..
09/15 NOVO NORDISK A/S : Share repurchase programme
09/15 NOVO NORDISK A/S : Novo Nordisk A/S - Share repurchase programme
09/11 NOVO NORDISK A/S : Saxenda(R) for the treatment of obesity receives positive 14-..
09/11 NOVO NORDISK A/S : Saxenda® for the treatment of obesity receives positive 14-1 ..
09/11 NOVO NORDISK A/S : FDA panel backs Novo Nordisk injection for obesity
09/11 NOVO NORDISK A/S : MEDIA ALERT: Denmark's Crown Prince Couple Helps Mark 90 Year..
09/10 NOVO NORDISK A/S : "Conjugated Factor Viii Molecules" in Patent Application Appr..
09/10 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
09/09 NOVO NORDISK A/S : FDA posts briefing materials prior to Advisory Committee meet..
09/09 NOVO NORDISK A/S : FDA posts briefing materials prior to Advisory Committee meet..
09/08 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
09/08 NOVO NORDISK A/S : Share repurchase programme
09/08 Novo Nordisk A/S - Share repurchase programme
09/04 NOVO NORDISK A/S : Trademark Application for "SAXENDA" Filed by Novo Nordisk A/S
09/04 NOVO NORDISK A/S : An Application for the Trademark "XULTIPHY" Has Been Filed by..
09/04 NOVO NORDISK A/S : Patent Issued for Method for Making Polypeptides
09/04 NOVO NORDISK A/S : Studies from Novo Nordisk Update Current Data on Proinsulin (..
09/04 NOVO NORDISK A/S : Kicks Off HeroPath™ Life Coach Program for Teens and Yo..
09/04 NOVO NORDISK A/S : New Findings from Novo Nordisk Update Understanding of Nephro..
09/04 NOVO NORDISK A/S : Researchers Submit Patent Application, "Efficient Induction o..
09/04 NOVO NORDISK A/S : New US study shows some minority groups with diabetes experie..
09/02 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
09/02DJNovo Nordisk Stops Inflammatory Disease Research
09/02 NOVO NORDISK A/S : discontinues its activities within inflammatory disorders
09/02 NOVO NORDISK A/S : Novo Nordisk discontinues its activities within inflammatory ..
09/01 NOVO NORDISK A/S : Denmark's Novo Nordisk launches Ryzodeg in Mexico
09/01 NOVO NORDISK A/S : Novo Nordisk A/S - Share repurchase programme
09/01 NOVO NORDISK A/S : Share repurchase programme
09/01 NOVO NORDISK A/S : Mexico first country to launch Ryzodeg®
08/28 NOVO NORDISK A/S : buys production plant in New Hampshire
08/28 NOVO NORDISK A/S : buys production plant in New Hampshire
08/28 NOVO NORDISK A/S : Trademark Application for "XULTIPHY" Filed
08/28 NOVO NORDISK A/S : An Application for the Trademark "SAXENDA" Has Been Filed by ..
08/27DJNovo Nordisk Buys US Manufacturing Plant
08/26DJADR Shares End Higher; WPP Shares Active
08/26 NOVO NORDISK A/S : Kicks Off HeroPath Life Coach Program for Teens and Young Adu..
08/26 NOVO NORDISK A/S : - Share repurchase programme
08/25 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
08/25 NOVO NORDISK A/S : Share repurchase programme
08/25 Novo Nordisk A/S - Share repurchase programme
08/25 NOVO NORDISK A/S : -Copenhagen joins 'Cities Changing Diabetes'
08/22 NOVO NORDISK A/S : Copenhagen joins ‘Cities Changing Diabetes’
08/21 NOVO NORDISK A/S : Patent Application Titled "Combined Use of a Modulator of Cd3..
08/21 BIOGEN IDEC : National Hemophilia Foundation and Impact Education to Host Pre- C..
08/20 NOVO NORDISK A/S : Data from Novo Nordisk Provide New Insights into Proinsulin (..
08/19 BIOGEN IDEC : National Hemophilia Foundation and Impact Education to Host Pre- C..
08/18 NOVO NORDISK A/S : Health and Human Services Department (HHS); Food and Drug Adm..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF